ArticlePloS one2025
Genomic and enzymatic insights into α-amylase-producing Bacillus spizizenii strains isolated from Isfahan province, Iran.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveα-Amylases represent a class of industrially critical enzymes widely employed in food processing, animal feed, and biotechnology sectors. While microbial sources, particularly Bacillus species, serve as preferred production platforms due to their efficiency and scalability, there remains a pressing need to discover novel strains with enhanced enzymatic properties from underexplored environments. This study investigated the isolation and characterization of high-performance α-amylase-producing bacteria from diverse ecological niches across Iran, including Golestan, Mazandaran, Gilan, Kurdistan, and Isfahan, with particular emphasis on their potential application in animal feed industries.
methodsStrains capable of producing amylase were extracted from environmental samples in Iran, subjected to screening through starch hydrolysis, and subsequently optimized for their enzymatic activity. The chosen strains underwent morphological and genetic characterization, including 16S/rpoB and whole-genome sequencing, followed by the purification of the enzyme and in silico analysis.
resultsThrough systematic screening of sixty bacterial isolates obtained from soil, water, and industrial effluent samples, four promising strains were selected based on their superior productivity indices (PI > 1.8) and enzymatic activity profiles. Among these, strains S1 and S3 (isolated from the Kuhrang water source and Gavkhouni Wetland in Isfahan province, respectively) demonstrated exceptional α-amylase production capabilities (reaching 34,121 U/g under optimal conditions) along with remarkable stability across broad pH (4-9) and temperature (30-80°C) ranges. Comprehensive genomic characterization, including whole-genome sequencing and phylogenetic analysis, identified these isolates as novel variants of Bacillus spizizenii, marking the first report of this species' α-amylase potential from Iranian ecosystems, specifically originating from Isfahan province. Further analysis revealed a 1980 bp GH13-family α-amylase gene encoding a 62 kDa enzyme with 93.6% sequence similarity to AmyE of B. subtilis, while molecular docking studies demonstrated strong binding affinities (-8.4 kcal/mol) with maltotetraose, supported by critical interactions with catalytic residues.
conclusionsThe combination of robust enzymatic activity, exceptional environmental tolerance, and confirmed genetic basis positions these B. spizizenii strains as highly promising candidates for industrial enzyme applications. This work not only expands the known diversity of high-performance α-amylase producers but also provides valuable insights into the biotechnological potential of underutilized Bacillus species from unique geographical sources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.